Head-to-head · WeighScore
Eclipse Medical Wellness vs Omada Health
The verdict
Eclipse Medical Wellness takes it — 63.2/100 to 55.6/100.
Eclipse Medical Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eclipse Medical Wellness is a Colorado-only, clinician-led telehealth weight-loss program.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eclipse Medical Wellness | Omada Health |
|---|---|---|
| WeighScore | 63.2/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #259 | #436 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | 1 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #259 · C
Strengths
- Clinician-led care with baseline and quarterly lab monitoring included
- Prescribes FDA-approved brand GLP-1 (Wegovy, Zepbound); compounded options also available
- Transparent care-plan pricing ($749 3-month starter, ~$149/mo ongoing) with nutrition support
- Includes a prior-authorization attempt plus dose-adjustment and side-effect monitoring
Where it loses points
- Colorado residents only
- Care-plan fees are separate from medication — you pay for the drug at your pharmacy
- Prescription is not guaranteed (depends on clinical evaluation)
- Small practice; no Terms or Privacy pages found on the site
Graded #436 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.